Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
As of close of business last night, Jade Biosciences Inc’s stock clocked out at $9.19, down -0.65% from its previous closing price of $9.25. In other words, the price has decreased by -$0.65 from its previous closing price. On the day, 4.16 million shares were traded. JBIO stock price reached its highest trading level at $9.83 during the session, while it also had its lowest trading level at $8.685.
Ratios:
To gain a deeper understanding of JBIO’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 32.01 and its Current Ratio is at 32.01. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
On May 07, 2025, Wedbush started tracking the stock assigning a Outperform rating and target price of $17.
On May 05, 2025, Stifel started tracking the stock assigning a Buy rating and target price of $19.Stifel initiated its Buy rating on May 05, 2025, with a $19 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jun 25 ’25 when Atlas Venture Fund XII, L.P. bought 28,977 shares for $10.48 per share.
Atlas Venture Associates XII, bought 235 shares of JBIO for $2,463 on Jun 25 ’25. On Jun 24 ’25, another insider, Atlas Venture Fund XII, L.P., who serves as the Shareholder of the company, bought 16,132 shares for $9.87 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, JBIO now has a Market Capitalization of 296247904 and an Enterprise Value of 127338784.
Stock Price History:
The Beta on a monthly basis for JBIO is 0.86, which has changed by -0.84554625 over the last 52 weeks, in comparison to a change of 0.12748289 over the same period for the S&P500. Over the past 52 weeks, JBIO has reached a high of $13.50, while it has fallen to a 52-week low of $5.06. The 50-Day Moving Average of the stock is 6.66%, while the 200-Day Moving Average is calculated to be 3.98%.
Shares Statistics:
It appears that JBIO traded 301.35K shares on average per day over the past three months and 994290 shares per day over the past ten days. A total of 32.24M shares are outstanding, with a floating share count of 27.01M. Insiders hold about 16.20% of the company’s shares, while institutions hold 34.74% stake in the company. Shares short for JBIO as of 1749772800 were 379537 with a Short Ratio of 1.26, compared to 1747267200 on 162947.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between $0 and $0 for the fiscal current year, implying an average EPS of $0.
